Role of Glial Cell Line‐Derived Neurotrophic Factor in the Maintenance of Adult Mesencephalic Catecholaminergic Neurons-Reference-Cited by-同舟云学术

Role of Glial Cell Line‐Derived Neurotrophic Factor in the Maintenance of Adult Mesencephalic Catecholaminergic Neurons

Published:2020-01-13 Issue:4 Volume:35 Page:565-576
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord

Author:

Enterría‐Morales Daniel¹²,López‐López Ivette¹²,López‐Barneo José¹²,d'Anglemont de Tassigny Xavier¹²

Affiliation:

1. Institute of Biomedicine of Seville, Virgen del Rocío University Hospital,/CSIC/University of Seville Seville Spain

2. Network Center for Biomedical Research on Neurodegenerative Diseases Seville Spain

Funder

Carlos III Health Institute

European Research Council

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.27986

Reference37 articles.

1. GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons

2. GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo

3. GDNF‐based therapies, GDNF‐producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson's disease;d'Anglemont de Tassigny X;Front Neuroanat,2015

4. Functional recovery in parkinsonian monkeys treated with GDNF

5. Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurotrophic Factors in Parkinson’s Disease: Clinical Trials;Stem Cell Biology and Regenerative Medicine;2024

2. In vitro induction of in vivo–relevant stellate astrocytes in 3D brain-derived, decellularized extracellular matrices;Acta Biomaterialia;2023-12

3. Hydrogel-based treatments for spinal cord injuries;Heliyon;2023-09

4. Extracellular matrix protein anosmin-1 overexpression alters dopaminergic phenotype in the CNS and the PNS with no pathogenic consequences in a MPTP model of Parkinson’s disease;Brain Structure and Function;2023-03-30

5. Extracellular matrix protein anosmin-1 overexpression regulates dopaminergic phenotype in the CNS and the PNS with no pathogenic consequences in MPTP model of Parkinson’s disease;2022-11-26